Physician profile
Keith E Junior
NPI 1811911449
$695.73
in general payments reported to CMS, 2019-2025
16 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.51 · 2020: $43.68 · 2022: $57.13 · 2023: $78.32 · 2024: $172 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $104.20 | 2019-2025 | Shingrix, Bexsero, Penmenvy |
| Astrazeneca Pharmaceuticals LP | $96.89 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Alkermes, INC. | $92.33 | 2019-2025 | Vivitrol |
| Hologic Sales and Service, LLC | $53.45 | 2025 | Aptima |
| Gilead Sciences, INC. | $45.35 | 2019-2020 | |
| Exact Sciences Corporation | $42.65 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $40.74 | 2025 | Ozempic, Rybelsus |
| Amgen INC. | $31.06 | 2024 | Repatha |
| Lilly USA, LLC | $29.48 | 2020-2024 | Zepbound, Mounjaro |
| Abbott Laboratories | $28.13 | 2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $26.22 | 2022-2025 | |
| Insulet Corporation | $25.00 | 2024 | Omnipod |
| Abbvie INC. | $24.56 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $22.06 | 2023 | Prehevbrio |
| Medtronic, INC. | $17.32 | 2024 | Minimed 780g |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Junior listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.